Hantech Bio-Technology Co

Hantech Bio-Technology Co Receivables

The Accounts Receivable of Hantech Bio-Technology Co (1294.TWO) as of Oct 29, 2026 is 80.56 M TWD. In the previous year, Accounts Receivable was 88.43 M TWD — a change of -8.90% (lower).

Receivables

80.56 MTWD

YoY

-8.90%

Last updated:

Accounts Receivable of Hantech Bio-Technology Co is 2024 80.56 M TWD. Accounts Receivable of Hantech Bio-Technology Co was 2023 88.43 M TWD. It decreases by -8.90% lower compared to the previous year.

The Hantech Bio-Technology Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2019
23.76 M TWD
Jan 1, 2020
31.23 M TWD
Jan 1, 2021
24.94 M TWD
Jan 1, 2022
50.06 M TWD
Jan 1, 2023
88.43 M TWD
Jan 1, 2024
80.56 M TWD
The Hantech Bio-Technology Co Receivables history
YEARReceivablesYoY
80.56 MTWD-8.90%
88.43 MTWD+76.63%
50.06 MTWD+100.75%
24.94 MTWD-20.14%
31.23 MTWD+31.46%
23.76 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hantech Bio-Technology Co Stock analysis

What does Hantech Bio-Technology Co do? Hantech Bio-Technology Co., Ltd. generates revenue by manufacturing and selling science-based health products, eco-friendly pouches, and dietary supplements. The company provides functional drinks, including health drinks and crystal jelly, and powder raw materials and capsules such as pearl powder and tortoise-deer concentrated powder. Products are sold to markets in China, Southeast Asia, and America, with packaging options ranging from square bags to wine bottle bags in capacities of 10-80ml (g). The firm focuses on functional drink production, offering health drinks and crystal jelly in various shaped pouches like round mouth bottles, Z-shaped bags, and stand-up bags. Powder raw materials and capsule products include pearl powder and tortoise-deer concentrated powder, targeting consumers seeking health and wellness solutions. Sales are distributed across China, Southeast Asia, and American regions. Hantech Bio-Technology Co., Ltd. serves customers in China, Southeast Asia, and America through its eco-friendly packaging solutions and science-based health products. The company’s product portfolio includes functional drinks, crystal jelly, and dietary supplements with diverse packaging formats. Sales are driven by the demand for health-focused products in these key markets. Hantech Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hantech Bio-Technology Co stock

Accounts Receivable of Hantech Bio-Technology Co is 80.56 M TWD in 2024.

Accounts Receivable of Hantech Bio-Technology Co changed from 88.43 M TWD to 80.56 M TWD, representing a -8.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Hantech Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Hantech Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Hantech Bio-Technology Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Hantech Bio-Technology Co